Professor Peter S Sever
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Hypertension management in the very old: less is more?
Event: ESC Congress 2019
Topic: Cardiovascular Nursing and Allied Professions
Session: Advancing the management of hypertension for nurses and allied professions
Benefit of LDL-C lowering with evolocumab on cardiovascular outcomes by age & sex: an analysis of the FOURIER trial
Event: ESC Congress 2018
Topic: Lipid-Lowering Agents
Session: PCSK9 inhibitors - For the many or the few?
Challenging the data.
Event: ESC Congress 2017
Topic: Endothelial function
Session: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention
Future perspectives in lipid lowering and CVD prevention.
Event: ESC Congress 2017
Topic: Atherosclerosis
Session: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention
PCSK9 inhibition & CV events: review of recent and upcoming hard endpoint outcome trials.
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition & cardiovascular outcomes: review of lipid targets and treatment strategies (EBAC Accredited)
ESC 365 is supported by
